CUL1 (Cullin 1): A Core Component of SCF E3 Ubiquitin Ligases in Cell Cycle and Cancer
Explore the gene, protein, expression, mutations, and disease associations of CUL1, a key regulator of ubiquitination and proteasomal degradation.
Gene Information Card
| Symbol | CUL1 |
|---|---|
| Full Name | Cullin 1 |
| Gene Type | Protein coding |
| Chromosomal Location | 7q36.1 |
| NCBI Gene ID | 8454 ncbi.nlm.nih.gov/gene/8454 |
| Ensembl ID | ENSG00000055130 |
| UniProt ID | Q13616 |
| OMIM ID | 603134 |
| HGNC ID | 2551 |
| Aliases | MGC149834, MGC149835 |
Description
CUL1 encodes cullin 1, a scaffold protein that forms the core of SCF (Skp1-Cullin-F-box) E3 ubiquitin ligase complexes. These complexes target specific proteins for ubiquitination and subsequent proteasomal degradation, regulating critical cellular processes including cell cycle progression, signal transduction, and transcription. CUL1 is essential for the degradation of key regulators such as cyclins, CDK inhibitors, and NF-κB pathway components.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Cancer (multiple types) | Dysregulation of SCF complexes leads to aberrant degradation of tumor suppressors and oncogenes, promoting tumorigenesis. | COSMIC; PMID: 23598260 |
| Hepatocellular carcinoma | CUL1 overexpression correlates with poor prognosis and increased proliferation. | PMID: 25742712 |
| Colorectal cancer | CUL1 upregulation promotes cell cycle progression and chemoresistance. | PMID: 23901092 |
| Gastric cancer | CUL1 overexpression is associated with aggressive tumor features. | PMID: 27058748 |
| Lung cancer | CUL1 alterations affect degradation of cell cycle regulators. | COSMIC; PMID: 24662924 |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Testis | 25.2 | High |
| Lymph node | 18.9 | High |
| Bone marrow | 17.3 | High |
| Spleen | 15.8 | Medium |
| Brain | 12.4 | Medium |
| Liver | 10.1 | Medium |
| Heart | 8.5 | Low |
| Kidney | 7.9 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| K-562 | 22.5 | Leukemia cell line; high expression |
| HeLa | 19.8 | Cervical carcinoma; high expression |
| A549 | 16.3 | Lung carcinoma; moderate expression |
| HepG2 | 14.2 | Hepatocellular carcinoma; moderate expression |
| MCF7 | 12.1 | Breast cancer; moderate expression |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.1234A>G (p.I412V) | Missense | 0.01% (COSMIC) | Potential impact on protein stability; observed in cancer samples |
| c.789C>T (p.S263F) | Missense | 0.005% (COSMIC) | Rare; functional impact unknown |
| c.1567G>A (p.V523M) | Missense | 0.002% (COSMIC) | Rare; possibly damaging (in silico) |
| c.1000_1001insA | Frameshift | 0.001% (COSMIC) | Predicted loss of function; truncating |
Mutation functional classification
Loss of Function (LOF)
Loss-of-function mutations in CUL1 are rare and may impair SCF complex assembly, leading to accumulation of substrates and disrupted cell cycle control.
Gain of Function (GOF)
Gain-of-function mutations are not well documented; overexpression is more common in cancer, enhancing degradation of tumor suppressors.
Dominant Negative (DN)
Dominant-negative mutations could interfere with SCF complex formation, but specific examples are not well characterized.
View complete mutation data:
Gene Ontology (GO)
| • ubiquitin protein ligase activity | • protein binding |
| • ubiquitin-dependent protein catabolic process | • SCF-dependent proteasomal ubiquitin-dependent protein catabolic process |
| • cell cycle | • G1/S transition of mitotic cell cycle |
| • nucleus | • cytoplasm |
Pathways
• SCF complex assembly
• Ubiquitin mediated proteolysis (KEGG hsa04120)
• Cell cycle (KEGG hsa04110)
• p53 signaling pathway (KEGG hsa04115)
Protein Summary
Cullin 1 is a 776-amino acid protein that serves as a molecular scaffold in SCF E3 ubiquitin ligases. It binds to the adaptor protein Skp1 and a RING finger protein (RBX1) to form the catalytic core, while an F-box protein provides substrate specificity. CUL1 undergoes neddylation, a post-translational modification that activates the complex. Through targeted ubiquitination, CUL1 controls degradation of cell cycle regulators (e.g., cyclin D1, p27), transcription factors (e.g., β-catenin, NF-κB), and other substrates, thereby influencing cell proliferation, survival, and differentiation.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| CUL1 Knockout HEK293T Cell Line | EDJ-KQ78133 | Human | 8454 | Details Get a Quote |
Displaying Records 1 To 1 Of 1 Records